Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NEUROTRIMIN FUNCTION INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2024/024565
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing an agent that suppresses cell aging and a drug that prevents or treats diseases and the like caused by cell aging. More specifically, the present invention is a cell aging suppressor that contains a neurotrimin (NTM) function inhibitor as an active ingredient and a drug or the like that contains the cell aging suppressor. The present invention is also an antibody that suppresses aging. The present invention is also a screening method for substances that suppress cell aging.

Inventors:
AKIYAMA TETSU (JP)
KAMOSHIDA YUKI (JP)
HAYASHI TOMOATSU (JP)
YAMAZUMI YUSUKE (JP)
ODA TAKEAKI (JP)
SHIKANAI MIMA (JP)
Application Number:
PCT/JP2023/026213
Publication Date:
February 01, 2024
Filing Date:
July 18, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV TOKYO (JP)
International Classes:
A61K39/395; A23L33/00; A61K31/7088; A61K38/02; A61K45/00; A61P1/14; A61P1/16; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P9/00; A61P9/10; A61P9/12; A61P11/00; A61P13/12; A61P17/00; A61P17/14; A61P19/02; A61P19/08; A61P21/00; A61P25/00; A61P25/16; A61P25/28; A61P27/02; A61P27/04; A61P27/06; A61P27/10; A61P27/12; A61P29/00; A61P31/00; A61P35/00; A61P43/00; C07K2/00; C12N15/113; C12N15/115; G01N33/15; G01N33/50
Foreign References:
JP2010133705A2010-06-17
US20220003787A12022-01-06
Other References:
YOON, I.K. ET AL.: "Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology.", EXPERIM. GERONTOL., vol. 39, no. 9, September 2004 (2004-09-01), pages 1369 - 1378, XP004601743, DOI: 10.1016/j.exger.2004.07.002
VENKANNAGARI, H. ET AL.: "Highly Conserved Molecular Features in IgLONs Contrast Their Distinct Structural and Biological Outcomes", J. MOL. BIOL., vol. 432, no. 19, 4 July 2020 (2020-07-04), pages 5287 - 5303, XP086267322, DOI: 10.1016/j.jmb.2020.07.014
Attorney, Agent or Firm:
OKUHARA Koji (JP)
Download PDF: